» Articles » PMID: 29069984

Treatment of Acute Myocardial Infarction in the Sub-arctic Region of Norway. Do We Offer an Equal Quality of Care?

Overview
Date 2017 Oct 27
PMID 29069984
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Patients, relatives, healthcare workers and administrators are concerned about the quality of care offered. We aimed to explore the treatment of acute myocatrdial infarction (AMI) in Northern Norway, compare it with the national figures, and document whether there is an equal quality of care or not. The retrospective study included data on patients' treatment for AMI. The following sources were employed. The Norwegian Patient Registry, National Quality of Care Database, Norwegian Myocardial Infarction Registry and data from the National Air Ambulance Services of Norway. The period 2012-2014/15 was studied and the variables were: incidence of AMI, gender and age adjusted rates of AMI and revascularization (PCI, CABG) based on patient's place of living (according to hospital catchment area) and 30-day survival rate. The annual incidence of AMI was 9% higher in the northern region. Significant incidence variations (2.7-5.9 AMI/1000 inhabitants) between the hospitals' catchment areas were revealed. The 30-day survival rate varied between 85.1-92.1% between hospitals. The variation in revascularization/AMI rate was 0.72-1.54. Air amublance services' availability varied through the day. In conclusion, significant variations in the AMI rate and an unequal service within the region was revealed.

Citing Articles

In need of percutaneous coronary intervention in an arctic setting- patients' experience of safety and quality of care: a qualitative study.

Krane A, Pettersen G, Lappegard K, Hanssen T Int J Circumpolar Health. 2023; 82(1):2273016.

PMID: 37899000 PMC: 10997295. DOI: 10.1080/22423982.2023.2273016.

References
1.
Krumholz H, Wang Y, Mattera J, Wang Y, Han L, Ingber M . An administrative claims model suitable for profiling hospital performance based on 30-day mortality rates among patients with an acute myocardial infarction. Circulation. 2006; 113(13):1683-92. DOI: 10.1161/CIRCULATIONAHA.105.611186. View

2.
Keeley E, Boura J, Grines C . Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet. 2003; 361(9351):13-20. DOI: 10.1016/S0140-6736(03)12113-7. View

3.
Hagen T, Hakkinen U, Belicza E, Fatore G, Goude F . Acute Myocardial Infarction, Use of Percutaneous Coronary Intervention, and Mortality: A Comparative Effectiveness Analysis Covering Seven European Countries. Health Econ. 2015; 24 Suppl 2:88-101. DOI: 10.1002/hec.3263. View

4.
Kesteloot H, Sans S, Kromhout D . Dynamics of cardiovascular and all-cause mortality in Western and Eastern Europe between 1970 and 2000. Eur Heart J. 2005; 27(1):107-13. DOI: 10.1093/eurheartj/ehi511. View

5.
Bohmer E, Hoffmann P, Abdelnoor M, Arnesen H, Halvorsen S . Efficacy and safety of immediate angioplasty versus ischemia-guided management after thrombolysis in acute myocardial infarction in areas with very long transfer distances results of the NORDISTEMI (NORwegian study on DIstrict treatment of.... J Am Coll Cardiol. 2009; 55(2):102-10. DOI: 10.1016/j.jacc.2009.08.007. View